1556: A Phase I/II Dose-Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy with Lemuteporfin in Men with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

Phase I ◽

Dose Escalation ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Dose Escalation Study ◽

Urinary Tract Symptoms ◽

PD22-12 EFFICACY OF DOSE ESCALATION OF TAMSULOSIN FOR THE TREATMENT IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA OF LOWER URINARY TRACT SYMPTOMS: A RANDOMISED, DOUBLE-BLIND, PHASE 3 TRIAL IN KOREAN MEN.

The Journal of Urology ◽

10.1016/j.juro.2016.02.1505 ◽

2016 ◽

Vol 195 (4S) ◽

Cited By ~ 2

Author(s):

Kyu Shik Kim ◽

Jae Heon Kim ◽

Seung Hwan Lee ◽

U-Syn Ha ◽

Deok Hyun Han ◽

...

Keyword(s):

Urinary Tract ◽

Dose Escalation ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phase 3 ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Transurethral photodynamic therapy (PDT) with lemuteporfin in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH): initial clinical experience

Urology ◽

10.1016/j.urology.2005.06.058 ◽

2005 ◽

Vol 66 (3) ◽

pp. 20 ◽

Cited By ~ 1

Author(s):

R. Perez-Marrero ◽

S. Goldenberg ◽

N. Shore ◽

E. Benaim ◽

R. Fay ◽

...

Keyword(s):

Photodynamic Therapy ◽

Urinary Tract ◽

Clinical Experience ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Lower Urinary ◽

Initial Clinical Experience

1242: Lower Urinary Tract Symptoms Severity and International Prostate Symptom Score Bother Question Correlate with Measures of Erectile and Ejaculatory Dysfunction in Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/s0022-5347(18)35387-4 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 337-337

Author(s):

Raymond C. Rosen ◽

Kevin T. McVary ◽

James Nuckolls ◽

Richard Payne ◽

Allen D. Seftel ◽

...

Keyword(s):

Urinary Tract ◽

Symptom Score ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Ejaculatory Dysfunction ◽

Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03408-8 ◽

2020 ◽

Vol 72 (1) ◽

Cited By ~ 5

Author(s):

Yi Sun ◽

Bo Peng ◽

Guo-Lin Lei ◽

Qiang Wei ◽

Lu Yang

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase 5 Inhibitors ◽

Urinary Tract Symptoms ◽

Phosphodiesterase 5 ◽

Analysis of the relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level.

10.26226/morressier.59b63e41d462b80292389623 ◽

2017 ◽

Author(s):

Fabiana Cancrini

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Serum Testosterone ◽

Prostatic Hyperplasia ◽

Serum Testosterone Level ◽

Total Serum ◽

Urinary Tract Symptoms ◽

The Relationship ◽

Faculty Opinions recommendation of Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157523.617702 ◽

2009 ◽

Author(s):

Peter Gilling ◽

Liam Wilson

Keyword(s):

Risk Factors ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Healthy Aging ◽

Prostatic Hyperplasia ◽

Community Based ◽

Urinary Tract Symptoms ◽

Aging Men ◽

Faculty Opinions recommendation of Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2111965.1706064 ◽

2010 ◽

Author(s):

Peter Gilling ◽

Liam Wilson

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Faculty Opinions recommendation of Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718145684.793486561 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Symptom Score ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Combined Therapy ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718266701.793494180 ◽

2014 ◽

Author(s):

Alexis Te ◽

Bilal Chughtai

Keyword(s):

Urinary Tract ◽

Flow Rate ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Flow ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Maximum Urinary Flow ◽